Sector News

UnitedHealth adds new C-suite member from Lockheed Martin

November 14, 2019
Life sciences

UnitedHealth Group Inc. has hired Patricia Lewis as its new chief human resources officer. She’ll serve in the office of the chief executive, the company said in an email. She’s replacing D. Ellen Wilson, who is retiring.

Previously, Lewis served in the same role at Lockheed Martin Corp. She’s also worked in human resources for IBM and DuPont.

At Lockheed Martin, Lewis had success starting a number of talent initiatives, including the STEM Scholarship Program and the Program Management Talent Initiative, with the goal of increasing the presence of traditionally underrepresented groups in STEM.

Lewis was recently featured in Politco’s “Women Rule” newsletter under the heading “Wisdom of the Week.” Her wisdom read, in part, “Bold leaders consistently demonstrate courage. Being courageous means taking risks even if you are faced with an uncertain outcome.”

UnitedHealth is Minnesota’s largest public company. In 2018, it had an income of $11.99 billion on $229.48 billion in sales. It employs 18,500 people in Minnesota alone, according to Business Journal research.

By: Carrigan Miller

Source: bizjournals.com

comments closed

Related News

May 4, 2024

Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio

Life sciences

Novartis will acquire Mariana’s lead candidate MC-339, a radioligand therapy (RLT) designed to target small-cell lung cancer. Last year, Mariana had raised $175m in a Series B round from several funds and pharma giant Eli Lilly.

May 4, 2024

Novo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q1

Life sciences

The company’s aspiration to expand the use of its obesity products to cardiovascular indications has been successful. In March, its blockbuster drug Wegovy was approved by the US Food and Drug Administration (FDA) for reducing the risk of cardiovascular diseases in obese or overweight adults.

May 4, 2024

Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn

Life sciences

Massachusetts-based Deciphera brings to the table an extensive kinase inhibitor pipeline, kinase drug discovery expertise, and a strong commercial and sales platform in the US and European markets that is meant to advance Ono’s capabilities and presence in the oncology space.

How can we help you?

We're easy to reach